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Abstract 
Previous studies that used carotid ultrasound have been largely conflicting in regards to whether or not patients after 
Kawasaki disease (KD) have a greater carotid intima-media thickness (CIMT) than controls. To test the hypothesis that 
there are significant differences between the values of CIMT expressed as absolute values and standard deviation 
scores (SDS) in children and adolescents after KD and controls, we reviewed 12 published articles regarding CIMT 
on KD patients and controls. The mean ± SD of absolute CIMT (mm) in the KD patients and controls obtained from 
each article was transformed to SDS (CIMT-SDS) using age-specific reference values established by Jourdan et al. (J: 
n = 247) and our own data (N: n = 175), and the results among these 12 articles were compared between the two 
groups and the references for comparison of racial disparities. There were no significant differences in mean absolute 
CIMT and mean CIMT-SDS for J between KD patients and controls (0.46 ± 0.06 mm vs. 0.44 ± 0.04 mm, p = 0.133, and 
1.80 ± 0.84 vs. 1.25 ± 0.12, p = 0.159, respectively). However, there were significant differences in mean CIMT-SDS for 
N between KD patients and controls (0.60 ± 0.71 vs. 0.01 ± 0.65, p = 0.042). When we assessed the nine articles on 
Asian subjects, the difference of CIMT-SDS between the two groups was invariably significant only for N (p = 0.015). 
Compared with the reference values, CIMT-SDS of controls was within the normal range at a rate of 41.6 % for J and 
91.6 % for N. These results indicate that age- and race-specific reference values for CIMT are mandatory for performing 
accurate assessment of the vascular status in healthy children and adolescents, particularly in those after KD consid-
ered at increased long-term cardiovascular risk.
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Background
Several studies showed that carotid intima-media thick-
ness (CIMT), a surrogate of atherosclerotic vessel wall 
changes, is sensitive to risk intervention and constitutes 
a reliable indicator of clinical outcome in adult subjects, 
even in a pediatric cohort (O’Leary et al. 1999; Jarvisalo 
et al. 2001). Moreover, these changes in the arterial wall 
occur earlier in the carotid arteries than in the coronary 
circulation, making the carotid arteries an ideal site for 
the detection of premature atherosclerotic disease (Bland 
et al. 1986).
Kawasaki disease (KD) is characterized by severe sys-
temic vasculitis of unknown etiology occurring in infants 
and young children (Kawasaki 1967). In the convalescent 
stage, compared with that in controls, the carotid arterial 
wall has been reported to have higher CIMT and lower 
distensibility in KD patients with persistent coronary 
artery lesions (CALs) (Noto et  al. 2001, 2009; Cheung 
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et al. 2007; Della Pozza et al. 2007; Cheung et al. 2008). 
Moreover, the CIMT, expressed as both unadjusted 
dimension and standard deviation scores (SDS), was 
greater among patients with KD than in control subjects; 
within the KD group, patients with CALs had greater 
CIMT than those without CALs (Meena et  al. 2013). 
However, some investigators have found no difference in 
CIMT between KD patients and controls (Kadono et al. 
2005; Ikemoto et  al. 2005; Gupta-Malhotra et  al. 2009; 
Lee et al. 2009; Selamet Tierney et al. 2013; Ishikawa and 
Iwasahima 2013).
In view of such conflicting clinical data, we wished 
to investigate directly the values of CIMT derived from 
the articles published to date. The methodology for the 
assessment of CIMT is of particular interest because the 
use of reference values on CIMT by LMS methods for 
childhood and adolescence is limited when comparing 
patients after KD and controls (Meena et  al. 2013). We 
speculated that there are significant differences between 
the values of absolute CIMT and those of SDS trans-
formed by LMS methods (CIMT-SDS) in children and 
adolescents after KD and controls. To test this hypoth-
esis, we reviewed previously published articles regarding 
CIMT in KD patients and controls.
Methods
Search
We attempted to find all publications describing CIMT in 
KD patients and controls. Reports on potentially eligible 
studies were retrieved via electronic databases (MED-
LINE, EMBASE, CENTRAL). The following (combina-
tion of ) medical subject heading and free text key words 
were used: “Kawasaki disease”, “Carotid intima-media 
thickness”, “Carotid arteries”, “Subclinical atherosclerosis”, 
and “Premature atherosclerosis”. Additional studies were 
sought by a manual research through reference lists of 
relevant publications, recent reviews, and editorials and 
through personal communication with experts in this 
field.
Study selection and data extraction
Two reviewers determined the eligibility of the retrieved 
studies independently, according to predetermined cri-
teria. The following criteria were accepted for inclusion 
in this study: (1) subjects with a diagnosis of KD, (2) an 
interval from initial onset of illness of ≥1  year, (3) KD 
patients and control subjects who underwent carotid 
ultrasound according to the Mannheim CIMT consen-
sus, (4) mean CIMT measurements at least in triplicate 
by the far wall of either right or left common carotid 
artery (CCA), and (5) the use of either manual trac-
ing with electronic calipers or a semiautomated border 
detection program for the assessment of CIMT. Subjects 
were excluded if they had potentially confounding coro-
nary risk factors (CRFs) including dyslipidemia, diabetes 
mellitus, hypertension, smoking history, or a family his-
tory of premature coronary artery disease (CAD), and if 
they were in duplicate reports or preliminary reports of 
data later presented in full. Data of the selected articles 
were extracted by two reviewers independently. Differ-
ences in judgment by the reviewers were resolved by dis-
cussion and consensus.
Data transformation and analysis
The LMS method is widely used for the description of 
pediatric anthropometric data, and allows the calculation 
of percentiles and accurately normalized SDS accounting 
for nonlinearity and a skewed distribution of the refer-
ence data set (Cole and Green 1992). The LMS method 
describes the distribution of the measurement Y by its 
median (M), the coefficient of variation (S), and a meas-
ure of skewness (L) required to transform the data to 
normality: SDS = {[Y/M(t)]L(t) − 1}/[L(t) × S(t)]. Here, Y 
is the individual measurement and L, M, and S originate 
from the specific reference values for each age (t).
The absolute mean ± SD of CIMT in the KD patients 
and controls was transformed to SDS using age-specific 
reference values for the mean CIMT established using 
the LMS method by Jourdan et  al. (2005) and our own 
data, and the results were compared between the KD 
patients and the controls and the two references for com-
parison of racial disparities. In this study, the mean age of 
the study population derived from each article was desig-
nated as the representative age for transformation.
Continuous variables were compared using unpaired t 
test or nonparametric Mann–Whitney u tests. Two-sided 
values of p < 0.05 were considered significant. All statis-
tical analyses were performed using SPSS version 10.0 
(SPSS Inc., Chicago, IL, USA).
Reference values for CIMT
Age-specific normative reference values for mean CIMT 
established by Jourdan et al. (J) consisted of 247 healthy 
Caucasian adolescents aged 10–20  years, as described 
previously (Jourdan et al. 2005). Meanwhile, our own ref-
erence values (N) consisted of 175 (male/female = 96/79) 
healthy Asian school-age subjects and their siblings aged 
6–20 years who were free from obesity or hypertension 
(Fig.  1). None took medication or had blood sampling 
data. All were nonsmokers with no history of cardiac 
disease. Anthropometric data of the reference subjects, 
namely of height, body mass index, systolic blood pres-
sure, diastolic blood pressure, and pulse pressure, were 
156.9  ±  12.6 (cm), 19.5  ±  2.0 (kg/m2), 109.0  ±  10.6 
(mmHg), 60.4 ±  8.9 (mmHg), and 47.8 ±  9.8 (mmHg), 
respectively.
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LMS estimates were obtained for age, and percen-
tile graphs were constructed from the L, M, and S data. 
In both of the references, mean CIMT measured from 
carotid ultrasound was obtained in a standard manner 
according to the Mannheim CIMT consensus, as pub-
lished previously (Touboul et al. 2012). In brief, the CCAs 
were assessed 1–2 cm proximal of the bifurcation over a 
range of 1 cm of the far wall. CIMT was defined as the 
distance between the leading edge of the lumen-intima 
interface and the media-adventitia interface of the far 
wall measured during diastole.
The distribution of CIMT did not differ significantly 
between male and female subjects at any given age in 
both references. Although CIMT was significantly asso-
ciated with age, height, body mass index, systolic blood 
pressure, and pulse pressure in both references, we con-
fined the reference to exclusively the age-specific refer-
ence because of the limitation of extractable data from 
each article in this study. Interobserver and intraob-
server variability studied in our laboratory with repeated 
recordings has shown coefficients of variance for mean 
CIMT of 7.3 and 5.0 %, respectively (Noto et al. 2001).
Results
Characteristics of the selected articles
Our search yielded 13 publications, which were all on 
case–control studies. One of these had to be excluded 
because it met 1 of the exclusion criteria. The charac-
teristics of the 12 remaining studies, published from 
2001 to 2013, are shown in (Table  1). The number of 
participants in the studies varied from 20 to 203. In 
total, 572 KD patients and 375 control subjects were 
assessed. The mean ages of the KD patients and con-
trols were 13.1  ±  3.6  years (range 6.5–20.9  years) and 
14.0  ±  3.7  years (range 7.9–21.3  years), respectively. 
About 65 % of the KD patients and 60 % of the controls 
were male. The mean interval from the initial onset of 
illness was 8.9 ±  5.2 years (range 2.6–18.6 years) in the 
KD patients. Except for the three articles with unknown 
treatments at the acute phase, about 85  % of the KD 
patients had been treated with intravenous immunoglob-
ulin during the acute phase of illness.
Comparison of CIMT between KD patients and control 
subjects
The absolute values of CIMT in the KD patients were 
significantly higher than those in the controls in 6 of 12 
(50 %) articles. Likewise, CIMT-SDS transformed by J or 
N in the KD patients was significantly higher than in the 
controls in 6 of 12 (50.0 %) articles in J and 7 of 12 (58.3 %) 
articles in N. On the whole, there were no significant dif-
ferences in mean absolute CIMT and mean CIMT-SDS 
transformed by J among the 12 articles between the two 
groups (0.46 ± 0.06 mm vs. 0.44 ± 0.04 mm, p = 0.133, 
and 1.80 ± 0.84 vs. 1.25 ± 0.12, p = 0.159, respectively). 
However, there were significant differences in mean 
CIMT-SDS for N among the 12 articles between the KD 
patients and the controls (0.60  ±  0.71 vs. 0.01  ±  0.65, 
p  =  0.042). Compared with the two reference values, 
CIMT-SDS in the controls for N was significantly lower 
Fig. 1 Age-specific reference values and percentile curve for CIMT. CIMT carotid intima-media thickness, L skewness coefficient, M median, S coef-
ficient of variation. Numbers indicate 3rd, 10th, 25th, 50th, 75th, 90th, and 97th percentiles
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than that for J (p < 0.001). Therefore, CIMT-SDS or N in 
the controls was within the normal range of mean ± SD 
in 11 of 12 (91.6 %) articles in comparison with that for J 
in 5 of 12 (41.6 %) articles (Fig. 2). When we assessed the 
9 articles on Asian subjects, the difference of CIMT-SDS 
between the KD patients and the controls was invari-
ably significant only for N (p = 0.015). In contrast, when 
we assessed the 3 articles on mainly Caucasian subjects, 
there was no significant difference in CIMT-SDS between 
the KD patients and the controls in either J (p = 0.163) or 
N (p = 0.162).
Discussion
Our results showed that CIMT-SDS among the 12 arti-
cles was significantly different between the KD patients 
and the controls despite the absolute CIMT not differ-
ing significantly between these two groups. Moreover, 
the normative reference values for CIMT applied in this 
study allowed comparison of the accurate vascular phe-
notypes of KD patients with those of healthy subjects.
Although it is well established that CIMT increases 
with age in adults, age-associated changes of CIMT 
in children have not been fully explored. As for the 
normative values of CIMT in children and adoles-
cents among previously published papers, mean CIMT 
(mean  ±  SD) in the distal common carotid artery has 
been reported as 0.46 ± 0.06 mm for 30 healthy children 
aged 14 ± 2 years (Tonstad et al. 1996), 0.47 ± 0.04 mm 
for 80 healthy controls aged 8–18 years (Wiegman et al. 
2004), 0.42 ± 0.04 mm for 28 controls aged 11 ± 1 years 
with normal serum cholesterol (Jarvisalo et  al. 2001), 
and 0.39  ±  0.03  mm for 48 controls aged 6  ±  3  years 
with normal cholesterol and triglyceride (Pauciullo 
et  al. 1994). Recently, Ishizu et  al. demonstrated that 
mean CIMT increased in a linear manner with age (esti-
mated CIMT =  [0.009 × age in years] + 0.35, r = 0.39, 
p  =  0.002) from the data of 60 healthy children aged 
5–14  years (Ishizu et  al. 2004). In addition, our data 
indicated that the normal predicted value of CIMT was 
calculated in a linear regression equation (normal pre-
dicted CIMT = [0.004 × age in years] + 0.381, r = 0.61, 
p  <  0.0001) derived from 35 healthy controls aged 
19.6 ± 7.2 years (Noto et al. 2009). There was no signifi-
cant difference between the normal predicted values of 
CIMT by Ishizu et  al. and those in our study, even in a 
different age-cohort; however, the coefficients of these 
equations were entirely different. This implies that a 
nonlinear correlation should be assumed in the assess-
ment of CIMT during childhood and adolescence. Fol-
lowing the establishment of age-specific reference values 
for CIMT by Jourdan et al., the reference ranges for sub-
jects aged 6–18 years base on the measurements in 1155 
Caucasian health controls have been published (Doyon 
et  al. 2013). In the present study, we established the 
Asian reference values of CIMT at ages 6–20  years and 
also applied the Caucasian reference values of CIMT by 
Jourdan et al. because of the necessity of reference values 
at age 19–20 years. In fact, the present study including 12 
Fig. 2 Difference of the values of CIMT-SDS between the two references in KD patients and controls among the 12 articles. CIMT-SDS standard 
deviation score of carotid intima-media thickness, Cont controls, KD Kawasaki disease patients, p p value
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articles features by far the largest adolescent population 
investigated. A cohort of subjects with a skewed age dis-
tribution like in this study should be assessed using valid 
age-related normative reference data.
Age-related increases in CIMT in healthy children 
do not appear to be strongly associated with pathologi-
cal atherosclerotic progression. Indeed, increased CIMT 
may be related to intima or media hypertrophy or both, 
and may be an adaptive response to changes in flow, 
wall tension, or lumen diameter. Therefore, increased 
CIMT is not synonymous with atherosclerosis, par-
ticularly in the absence of carotid plaque. In the con-
valescent stage, even in transient coronary ectasia and 
regressed coronary lesions, intimal thickness has been 
detected by intravascular ultrasonography (IVUS) after 
KD (Mitani et  al. 2009). In addition, increased arterial 
stiffness determined by pulse wave velocity occurred in 
KD patients with CALs (Cheung et al. 2007). Moreover, 
we have shown that observed higher CIMT may indicate 
the development of post-inflammatory arteriosclerotic 
remodeling after KD (Noto et  al. 2012). These previous 
studies demonstrated that KD with CALs eventually led 
to the development of post-inflammatory arterioscle-
rotic remodeling characterized by luxuriant intimal pro-
liferation and neoangiogenesis (Suzuki et  al. 2000). On 
the other hand, it remains unclear whether the vessels 
in KD patients with CALs may more easily develop ath-
erosclerotic changes. Recently, Chen et al. demonstrated 
pathophysiological findings on the marked acceleration 
of atherosclerosis following Lactobacillus casei-induced 
coronary vasculitis in a mouse model of KD (Chen et al. 
2012). In a scientific statement from the American Heart 
Association’s expert panel, KD was listed among the eight 
pediatric diseases that are associated with a high risk of 
accelerated atherosclerosis in children (Kavey et al. 2006). 
Although there is no published data linking childhood 
CIMT measures with any clinical outcomes of interest for 
KD patients, longitudinal accurate CIMT measurements 
in individuals may provide a valuable tool for identifying 
and selecting candidates for early intervention, especially 
in KD patients with CALs.
Previous studies that used carotid ultrasound have 
been largely conflicting in regards to whether or not 
KD patients have a higher CIMT than normal controls. 
Although the exact reasons for these conflicting results 
remain unclear, differences in study populations, racial 
differences, methodology, pubertal status, latent coro-
nary risk factors (CRFs), and systemic inflammation may 
play a role. In this study, the mean values of CIMT-SDS 
for N were more significantly different than those of 
CIMT-SDS for J between the KD patients and the con-
trols among the 12 articles. Of note, compared with the 
normative references, controls were distributed within 
the normal range at a rate of 41.6 % for J and 91.6 % for N. 
These results indicate that not only meticulous selection 
of control subjects but also use of age- and race-specific 
reference values for CIMT are mandatory for performing 
accurate assessment of the vascular status in healthy chil-
dren and adolescents and particularly in those after KD. 
Hence, we suspect that these conflicting results on CIMT 
in KD patients and controls may have been partially 
caused by the selection bias of healthy control subjects.
Several limitations might have influenced the results of 
this study. First, the sample size may be considered lim-
ited for constructing age-specific percentile curves and a 
reference table. The limited sample size may be compen-
sated for by the absence of gender differences of CIMT. 
Second, we could not exclude healthy reference controls 
with latent CRFs including dyslipidemia and diabetes 
mellitus. Third, as the representative age for transforma-
tion, we applied not the individual ages but the mean age 
of the study population derived from each article, ignor-
ing the age distribution of the subjects. Fourth, there is 
no published database focused on the childhood CIMT 
across race/ethnicity, age, and gender as yet. We could 
not perform accurate comparison across these variables 
between KD patients and controls. Finally, although the 
reproducibility of CIMT measurements should be strictly 
monitored to identify a subtle change of this parameter 
with age, we are unsure as to how the quality controls 
were being performed at each institute. These results 
should thus be interpreted with caution.
Conclusions
Our results indicate that age and race-specific reference 
values for CIMT are mandatory for performing accurate 
assessment of the vascular status in healthy children and 
adolescents, particularly in those after KD. Future study 
with a large number of subjects per age group for the 
establishment of accurate reference values is warranted 
in children and adolescents considered at increased long-
term cardiovascular risk.
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